COM:GUARDANTHEALTH
Guardant Health, Inc.
- Stock
Last Close
30.98
22/11 21:00
Market Cap
3.38B
Beta: -
Volume Today
2.14M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 5.03M - | 8.21M 63.32% | 12.16M 48.07% | 18.95M 55.85% | 26.70M 40.88% | 41.14M 54.10% | 56.77M 38.01% | ||
average payables | 4.08M - | 7.82M 91.78% | 13.42M 71.60% | 11.77M 12.30% | 12.46M 5.88% | 96.70M 676.07% | 87.91M 9.09% | ||
average receivables | 8.14M - | 24.24M 197.73% | 41.84M 72.61% | 50.64M 21.04% | 75.48M 49.04% | 97.45M 29.12% | 93.02M 4.55% | ||
book value per share | 1.13 - | 4.36 287.23% | 15.89 264.15% | 8.81 44.55% | 13.32 51.12% | 6.37 52.19% | 0.59 90.75% | 1.42 140.58% | |
capex per share | -0.02 - | -0.13 408.66% | -0.66 423.11% | -0.23 64.64% | -0.55 135.99% | -0.74 33.58% | -0.76 2.36% | -0.18 75.87% | |
capex to depreciation | -0.48 - | -1.73 260.83% | -2.83 64.08% | -1.56 44.76% | -3.37 115.15% | -3.37 0.12% | -2.15 36.07% | -0.48 77.82% | |
capex to operating cash flow | 0.05 - | 0.12 158.50% | 0.28 125.06% | 0.45 61.35% | 0.52 15.19% | 0.36 30.99% | 0.25 30.27% | 0.06 74.82% | |
capex to revenue | -0.07 - | -0.18 157.68% | -0.22 23.67% | -0.10 55.46% | -0.19 89.89% | -0.20 6.51% | -0.17 14.19% | -0.04 78.92% | |
cash per share | 1.35 - | 3.13 132.34% | 13.78 340.31% | 5.77 58.12% | 18.41 219.00% | 9.21 49.99% | 9.90 7.50% | 10.44 5.44% | |
days of inventory on hand | 45.68 - | 84.12 84.14% | 77.17 8.26% | 78.35 1.53% | 89.60 14.36% | 91.09 1.66% | 120.48 32.26% | 271.12 125.04% | |
days payables outstanding | 52.08 - | 57.70 10.78% | 89.89 55.80% | 83.60 7.01% | 28.95 65.37% | 52.21 80.32% | 410.51 686.34% | ||
days sales outstanding | 50.52 - | 93.64 85.34% | 143.72 53.48% | 81.70 43.15% | 67.85 16.96% | 95.39 40.59% | 78.97 17.22% | 57.46 27.23% | |
debt to assets | 0.15 - | 0.00 98.69% | 0.00 80.86% | 0.04 11,313.12% | 0.38 796.23% | 0.62 65.67% | 0.85 36.48% | 0.74 12.74% | |
debt to equity | 0.21 - | 0.00 99.00% | 0.00 79.06% | 0.05 11,217.53% | 0.66 1,200.60% | 2.13 223.65% | 22.75 968.32% | 8.36 63.28% | |
dividend yield | 0.00 - | 0.00 - | |||||||
earnings yield | -0.02 - | -0.04 80.37% | -0.07 103.65% | -0.01 87.12% | -0.02 104.48% | -0.04 93.74% | -0.24 520.29% | -0.16 32.80% | |
enterprise value | 2.26B - | 2.21B 2.44% | 1.00B 54.54% | 6.97B 595.18% | 12.58B 80.52% | 11.00B 12.55% | 4.01B 63.58% | 3.22B 19.60% | |
enterprise value over ebitda | -57.34 - | -31.40 45.24% | -12.08 61.52% | -101.68 741.55% | -52.17 48.69% | -28.81 44.78% | -6.16 78.63% | -5.70 7.33% | |
ev to operating cash flow | -61.58 - | -30.53 50.42% | -13.89 54.51% | -147.86 964.65% | -121.06 18.13% | -52.64 56.52% | -12.95 75.40% | -9.91 23.44% | |
ev to sales | 89.53 - | 44.25 50.58% | 11.06 75.00% | 32.51 193.92% | 43.88 34.97% | 29.44 32.89% | 8.91 69.73% | 5.71 35.91% | |
free cash flow per share | -0.54 - | -1.15 111.09% | -3.04 164.58% | -0.76 75.15% | -1.62 114.55% | -2.80 73.03% | -3.79 35.06% | -3.08 18.54% | |
free cash flow yield | -0.02 - | -0.04 111.09% | -0.08 126.65% | -0.01 88.04% | -0.01 30.08% | -0.03 122.96% | -0.14 396.66% | -0.11 18.09% | |
graham net net | 0.88 - | 2.83 220.91% | 12.76 350.56% | 4.99 60.90% | 9.54 91.25% | -5.31 155.69% | -4.30 18.96% | -3.23 25.00% | |
graham number | 4.07 - | 10.75 164.28% | 31.63 194.24% | 12.19 61.47% | 27.51 125.76% | 23.32 15.22% | 9.21 60.50% | 11.68 26.80% | |
income quality | 0.80 - | 0.87 9.09% | 0.86 1.30% | 0.69 18.91% | 0.42 39.25% | 0.54 28.73% | 0.47 12.97% | 0.68 43.37% | |
intangibles to total assets | 0 - | 0.03 Infinity% | 0.01 47.89% | 0.02 46.34% | 0.01 55.85% | 0.01 7.49% | 0.01 17.52% | 0.01 26.37% | |
interest coverage | -14.53 - | -28.35 95.16% | -74.29 162.03% | -69.75 6.12% | -53.49 23.30% | -159.49 198.14% | -211.24 32.45% | 219.06 203.70% | |
interest debt per share | 0.28 - | 0.05 83.24% | 0.05 1.52% | 0.46 851.10% | 8.81 1,820.26% | 13.58 54.15% | 13.43 1.17% | 11.82 11.99% | |
inventory turnover | 7.99 - | 4.34 45.69% | 4.73 9.00% | 4.66 1.51% | 4.07 12.56% | 4.01 1.63% | 3.03 24.39% | 1.35 55.56% | |
invested capital | 0.21 - | 0.00 99.00% | 0.00 79.06% | 0.05 11,217.53% | 0.66 1,200.60% | 2.13 223.65% | 22.75 968.32% | 8.36 63.28% | |
market cap | 2.28B - | 2.28B 0% | 1.14B 49.81% | 7.08B 519.44% | 12.57B 77.51% | 10.13B 19.36% | 2.78B 72.57% | 3.03B 9.00% | |
net current asset value | 66.22M - | 208.60M 215.01% | 406.54M 94.89% | 482.82M 18.76% | 972.17M 101.36% | -445.37M 145.81% | -358.21M 19.57% | -280.63M 21.66% | |
net debt to ebitda | 0.42 - | 1.02 142.88% | 1.69 65.84% | 1.60 5.13% | -0.06 103.85% | -2.27 3,586.18% | -1.89 17.08% | -0.34 81.95% | |
net income per share | -0.65 - | -1.18 80.37% | -2.80 137.74% | -0.75 73.23% | -2.53 237.26% | -3.80 50.36% | -6.41 68.69% | -4.28 33.17% | |
operating cash flow per share | -0.52 - | -1.02 96.77% | -2.37 132.43% | -0.52 78.09% | -1.07 104.87% | -2.06 93.56% | -3.03 46.80% | -2.90 4.19% | |
payables turnover | 7.01 - | 6.33 9.73% | 4.06 35.82% | 4.37 7.53% | 12.61 188.74% | 6.99 44.54% | 0.89 87.28% | ||
receivables turnover | 7.22 - | 3.90 46.05% | 2.54 34.85% | 4.47 75.91% | 5.38 20.42% | 3.83 28.87% | 4.62 20.80% | 6.35 37.42% | |
research and ddevelopement to revenue | 0.43 - | 0.51 19.25% | 0.56 9.10% | 0.40 28.06% | 0.52 29.84% | 0.70 34.78% | 0.83 18.04% | 0.65 21.70% | |
return on tangible assets | -0.40 - | -0.25 37.09% | -0.15 41.06% | -0.07 51.02% | -0.11 52.11% | -0.18 60.89% | -0.41 133.27% | -0.27 34.15% | |
revenue per share | 0.36 - | 0.70 97.40% | 2.98 322.98% | 2.37 20.63% | 2.94 24.28% | 3.69 25.41% | 4.40 19.29% | 5.04 14.46% | |
roe | -0.58 - | -0.27 53.42% | -0.18 34.71% | -0.08 51.73% | -0.19 123.18% | -0.60 214.52% | -10.88 1,723.38% | -3.02 72.22% | |
roic | -0.45 - | -0.25 45.15% | -0.19 22.22% | -0.09 52.19% | -0.12 26.58% | -0.18 57.48% | -0.33 81.53% | -0.34 1.79% | |
sales general and administrative to revenue | 0.39 - | 0.74 87.79% | 0.40 45.89% | 0.29 28.27% | 0.67 134.74% | 0.55 17.74% | 0.36 34.05% | 0.28 24.25% | |
shareholders equity per share | 1.13 - | 4.36 287.23% | 15.89 264.15% | 8.81 44.55% | 13.32 51.12% | 6.37 52.19% | 0.59 90.75% | 1.42 140.58% | |
stock based compensation to revenue | 0.08 - | 0.07 5.67% | 0.08 2.65% | 0.08 4.63% | 0.50 535.52% | 0.41 19.36% | 0.21 48.03% | 0.16 23.59% | |
tangible asset value | 79.70M - | 299.87M 276.26% | 517.15M 72.46% | 829.29M 60.36% | 1.34B 61.11% | 627.51M 53.03% | 45.16M 92.80% | 146.41M 224.19% | |
tangible book value per share | 1.13 - | 4.24 276.26% | 17.01 301.14% | 9.15 46.19% | 13.70 49.70% | 6.19 54.80% | 0.44 92.86% | 1.31 195.79% | |
working capital | 88.81M - | 223.31M 151.44% | 422.05M 89.00% | 524.62M 24.30% | 1.82B 247.21% | 919.44M 49.52% | 998.37M 8.59% | 1.14B 14.30% |
All numbers in USD (except ratios and percentages)